Avantor, Inc.
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials…
Chemicals - Specialty
US, Radnor [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | -0.08 | 1.61 | 1.61 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | 2.40 | 18.91 | 18.47 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 1.34 | 7.87 | 7.77 | |
| Cash | -9.74 | 0.37 | 0.41 | |
| Capex | 31.59 | -0.05 | -0.07 | |
| Free Cash Flow | -46.95 | 0.16 | 0.30 | |
| Revenue | -2.74 | 2.48 | 2.55 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | 2.58 | 0.34 | 0.33 | |
| Operating Margin | -5.16 | 0.10 | 0.11 | |
| ROA | -37.67 | < 0.005 | < 0.005 | |
| ROE | -39.64 | 0.01 | 0.02 | |
| ROIC | -14.91 | 0.01 | 0.01 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of AVTR is permitted for members.
5
Growth
The "Growth Entry" for the Focus of AVTR is permitted for members.
6
Leverage & Liquidity